服务热线
15339069646服务热线
15339069646| Item | Cat. No. | Type | Clone No |
| Anti-IL2RA/CD25 mAbs [Vopikitug Biosimilar] (MABL-5432) | MABL-5432 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-ICOS/CD278 mAbs [Vopratelimab Biosimilar] (MABL-5433) | MABL-5433 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-TNFSF7/CD70/CD27LG mAbs [Vorsetuzumab Biosimilar] (MABL-5434) | MABL-5434 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-FOLH1/GCPII/PSMA;CD3E mAbs [Voxalatamab Biosimilar] (MABL-5435) | MABL-5435 | ELISA, FACS, Functional assay, in vivo binding | G4;G4, Kappa;Lambda |
| Anti-CTLA4/CD152;PDCD1/CD279/PD1 mAbs [Vudalimab Biosimilar] (MABL-5436) | MABL-5436 | ELISA, FACS, Functional assay, in vivo binding | G1;G1, Kappa;Kappa |
| Anti-KDR/CD309/VEGFR2 mAbs [Vulinacimab Biosimilar] (MABL-5437) | MABL-5437 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-IL17A mAbs [Vunakizumab Biosimilar] (MABL-5438) | MABL-5438 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-STEAP1;CD3 mAbs [Xaluritamig Biosimilar] (MABL-5439) | MABL-5439 | ELISA, FACS, Functional assay, in vivo binding | G1;na, Kappa;Lambda |
| Anti-IL17A mAbs [Xeligekimab Biosimilar] (MABL-5440) | MABL-5440 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-IGF1 and IGF2 mAbs [Xentuzumab Biosimilar] (MABL-5441) | MABL-5441 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
| Anti-PDL1/CD274;TNFRSF9/CD137/4-1BB mAbs [Xirestomig Biosimilar] (MABL-5442) | MABL-5442 | ELISA, FACS, Functional assay, in vivo binding | G1;na, Lambda;Lambda |
| Anti-BTLA/CD272 mAbs [Zadoprubart Biosimilar] (MABL-5443) | MABL-5443 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-MAPT mAbs [Zagotenemab Biosimilar] (MABL-5444) | MABL-5444 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-CTLA4/CD152 mAbs [Zalifrelimab Biosimilar] (MABL-5445) | MABL-5445 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-MASP3 mAbs [Zaltenibart Biosimilar] (MABL-5446) | MABL-5446 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-C5 mAbs [Vilobelimab Biosimilar] (MABL-5416) | MABL-5416 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-ADCYAP1/PACAP mAbs [Vipalanebart Biosimilar] (MABL-5417) | MABL-5417 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-CD3E mAbs [Visilizumab Biosimilar] (MABL-5418) | MABL-5418 | ELISA, FACS, Functional assay, in vivo binding | G2, Kappa |
| Anti-SIRPA mAbs [Vislarafusp Biosimilar] (MABL-5419) | MABL-5419 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-GDF15/MIC1/MIC-1/NAG1/NAG-1/PTGFB mAbs [Visugromab Biosimilar] (MABL-5420) | MABL-5420 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
联系我们
Copyright © 2012-2029 西安迈博睿（Mabioway）生物科技有限公司 版权所有
地址：陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话：15339069646 邮箱：info@mabioway.cn